Trisure (NIPT Standard) is a non-invasive prenatal test that provides expectant parents with early, accurate insights into their baby’s genetic health. It helps assess the risk of certain chromosomal abnormalities—offering reassurance and support during pregnancy without the risks of invasive procedures. This test includes screening for: Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome), Sex Chromosome Aneuploidies, Other Autosomal Aneuploidies (Chromosomes 1–12, 14–17, and 19–22), Thalassemia Panel (Carrier Screening), Fetal Sex Determination, and Fetal Fraction Reporting.
14 days upon receipt of sample in lab.